Biotech

All Articles

Former Seagen CEO introduces brand-new start-up Ottimo Pharma

.After antibody-drug conjugate (ADC) professional Seagen was actually marketed to Pfizer in 2015 for...

Ironwood creates further purpose $1B GI medication with new subgroup data

.On the heels of a period 3 win that fell short to excite real estate investors, Ironwood Pharmaceut...

Novartis inks $150M deal for autoimmune molecular adhesive

.Don't cease Monte Rosa Rehabs now. The Boston-based biotech is having a ball after signing a manage...

Jade carves out director staff with Chinook vets-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our summary of significant leadership hirings, shootings...

Septerna goes public along with upsized offering of $288M

.Commemorating his provider's upsized initial public offering (IPO), Septerna CEO Jeffrey Finer call...

AbbVie creates Richter richer, spending $25M to form breakthrough pact

.AbbVie has come back to the source of its own antipsychotic giant Vraylar seeking one more runaway ...

GenSight gets in last full weeks of cash path as income flow slips by of reach

.GenSight Biologics is actually weeks off of losing loan. Once again. The biotech only has adequate ...

AZ licenses disposed of uncommon condition medicine to Monopar Rehabs

.Monopar Therapies is actually recovering a medicine coming from the scrap heap of AstraZeneca's rar...

Arcus' new HIF-2a information in renal cancer cells hint at potential upper hand over Merck's Welireg, professionals point out

.With brand-new information out on Arcus Biosciences' experimental HIF-2a inhibitor, one group of ex...

Roche wagers as much as $1B to extend Dyno genetics therapy shipping deal

.After developing a gene therapy partnership along with Dyno Therapies in 2020, Roche is back for mo...